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Diﬀerent therapeutic options are being used for chronic coronary artery disease (CAD). We report about a 51-year-old female
with CAD and refractory angina pectoris despite maximally tolerated medical therapy and after both percutaneous coronary
intervention (PCI) and coronary artery bypass grafting (CABG). The patient received cardiac shock wave therapy (CSWT) over
a period of 6 month. There was no arrhythmia during or after treatment; enzyme levels were normal at all times. PET imaging
showed a substantial improvement of myocardial stress perfusion. Since the patient reported that she now was fully capable to deal
with her everyday life, further treatment options were postponed. Our case report suggests that ultrasound-guided CSWT is able
to improve symptoms and perfusion in ischemic myocardium.
Copyright © 2009 Christian Prinz et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Diﬀerent therapeutic options are being used for chronic
coronaryartery disease (CAD), including medical treatment,
percutaneous coronary intervention (PCI), and coronary
artery bypass grafting (CABG). However, a growing number
of patients exists who suﬀer from disabling angina despite,
or after having undergone, all these modalities. For this chal-
lenging subset of patients with so-called chronic refractory
angina, several alternative therapies such as neurostimulator
implantation,laserrevascularisation,orangiogenesisbygene
or cell therapy [1]m a yb ee ﬀective. However, these modal-
ities are invasive, expensive, or still at a preclinical stage.
Ultrasound-guided cardiac shock wave therapy (CSWT [2]),
on which we report now, is another modality to deal
with chronic refractory angina. We used CSWT to improve
myocardial ischemia in a patient with severe CAD and
refractory angina pectoris.
2. Case Presentation
A 51-year-old female with CAD, arterial hypertension, and
diabetes mellitus presented with disabling angina (CCS
class III-IV) despite maximally tolerated medical therapy,
and after both PCI and CABG. Three years earlier, triple-
vessel CAD had been diagnosed after a non-ST-elevation
anterior myocardial infarction. Subsequently, the patient
underwent CABG surgery with venous grafts to the left
anterior descendent artery (LAD), to a marginal branch
(Rm), and to the posterior descendent branch (PDA) from
the right coronary artery (RCA).
During the current evaluation, echocardiography
showed a preserved global left ventricular function with an
ejection fraction of 55%, and without signiﬁcant regional
hypokinesia. A bicycle stress test was terminated at 75 watts
because of dyspnoea with ST segment depression in leads
V5 and V6. A repeat coronary angiography documented2 Case Reports in Medicine
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Figure 1: (a)–(e) PET imaging before (a)–(d) and after (e) 18 sessions of ultrasound-guided CSWT focused on the septal and inferior wall
in this patient with chronic refractory angina and without a revascularization option. (a) Bulleye map of myocardial viability FDG PET at
baseline, showing preserved viability (red). (b) Perfusion at rest as assessed with N-13-ammonia PET with quantitatively normal perfusion
values. (c) Perfusion with N-13-ammonia under adenosine stress at baseline revealed severely reduced perfusion values in the anterior and
anteroseptal wall, the apical half of the lateral wall and in the apex. (d) and (e) Blownup maps of stress perfusion at baseline (D=C) and
followup (e) with improved stress perfusion in parts of the septum and the adjacent inferior wall.
occlusion of the LAD, the Rm, and the RCA. The venous
grafts to LAD and Rm were fully functional, the RCA
bypass was occluded. There was no possibility for a repeat
revascularization. Myocardial viability and perfusion at rest
and stress (under adenosine induced vasodilation) were
assessed by positron emission tomography (PET) imaging,
with F-18-FDG and N-13-ammonia, respectively. Areas of
decreased stress perfusion were found predominantly in the
apex and the anterior and inferior septal wall (Figures 1(c)
and 1(d)), while viability (Figure 1(a)) and perfusion at rest
(Figure 1(b)) were preserved.
As an alternative to neurostimulator implantation the
patient was oﬀered cardiac shock wave therapy, and received
18 sessions of CSWT over a period of 6 months focused
by 2D echocardiographic guidance to the most ischemic
myocardial segments. Serum concentrations of cardiac
enzymes (CK, CK-MB, and troponin I) were measured
after each shock wave application. There was no arrhythmia
during or after treatment; enzyme levels were normal at all
times.
Afterthecompletetreatmentcourse,thepatientreported
signiﬁcantimprovementofangina(CCSII),supportedbyan
improvement in bicycle exercise capacity to 100 watt. On 2D
echocardiography, no signiﬁcant changes could be observed.
Repeated PET imaging showed a substantial improvement
of myocardial stress perfusion predominantly in the septum
and the adjacent posterior wall (Figures 1(d) and 1(e)).
Since the patient reported that she now was fully capable to
deal with her everyday life, further treatment options were
postponed.
3. Discussion
The medical use of electrohydraulic shock waves includes
lithotripsy in urology and gastroenterology, or treatment of
speciﬁc orthopaedic conditions. As compared to these appli-
cations,cardiacshockwavetherapyusesshockwavesemitted
with a nondestructive energy level reduced by a factor of
>10. In cultured endothelial cells, it was demonstrated that
angiogenic factors are upregulated when exposed to these
energy levels [2]. In an animal model, Nishida et al. showed
that R-wave-triggered shock waves induce angiogenesis and
markedly ameliorate myocardial ischemia and dysfunction
without adverse eﬀect [3].
Inthispatient,asigniﬁcantimprovementofanginaanda
moderate improvement of objective exercise tolerance could
be achieved by 18 sessions of CSWT over a period of 6
months completely noninvasively, and without any adverse
eﬀect. Particularly impressive was the improvement of stress
perfusion in the targeted regions as shown by PET imaging.
Our case report suggests that ultrasound-guided CSWT
is able to improve symptoms and perfusion in ischemicCase Reports in Medicine 3
myocardium which is beyond mechanical revascularization.
However, a controlled trial is needed to deﬁne the role of
CSWTinthearmamentariumforthesechallengingpatients.
References
[1] S. N. Khan and D. P. Dutka, “A systematic approach to
refractory angina,” Current Opinion in Supportive and Palliative
Care, vol. 2, no. 4, pp. 247–251, 2008.
[2] A.GutersohnandG.Gaspari,“Shockwavesupregulatevascular
endothelial growth factor m-RNA in human umbilical vascular
endothelial cells,” Circulation, vol. 102, supplement 1, pp. 1–18,
2000.
[3] T. Nishida, H. Shimokawa, K. Oi, et al., “Extracorporeal cardiac
shock wave therapy markedly ameliorates ischemia-induced
myocardial dysfunction in pigs in vivo,” Circulation, vol. 110,
no. 19, pp. 3055–3061, 2004.